Taiwan Liposome Company

Developer of nanomedicines for oncology, ophthalmology, osteoarthritis and pain management

placeTaipei, Taipei, Taiwan calendar_todayFounded 1997 groups112 employees language tlcbio.com

Registered entities

Social engagement

Social engagement: 864 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Private equity120%
Other / undisclosed360%

Recent activity

25 Jun 2026
Event
Pre-listing conference
14 Apr 2026
Event
OARSI 2026
7 Apr 2026
Product launch
GenosphereTM Precision tLNP In Vivo CART
Coming soon